Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Industry News

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

November 17, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Hydration Based on Ventricular Pressure is Effective in Reducing Kidney Damage in Patients Undergoing Cardiac Catheterization

October 25, 2012

News Industry News

PLC Systems' RenalGuard® Demonstrated At Major Latin American Cardiology Meeting

August 13, 2012

News Industry News

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

July 02, 2012

News Industry News

Echo May Not Provide Best Picture for TAVI

November 06, 2011

News Industry News

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

October 14, 2011

News Industry News

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

September 22, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

News Industry News

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 02, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

April 04, 2011

Advertisement

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Hydration Based on Ventricular Pressure is Effective in Reducing Kidney Damage in Patients Undergoing Cardiac Catheterization

PLC Systems' RenalGuard® Demonstrated At Major Latin American Cardiology Meeting

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

Echo May Not Provide Best Picture for TAVI

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content